SCHEMBL31240406

SCHEMBL31240406

Nc1n[nH]c2ccc(-c3ccnc(NCCc4ccncc4)c3)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 8/20 0.60
▸ PDPK1 O15530 3/20 0.47
▸ MKNK1 Q9BUB5 3/20 0.43
▸ MKNK2 Q9HBH9 3/20 0.43
▸ LRRK2 Q5S007 1/20 0.43
▸ MAP4K4 O95819 4/20 0.43
▸ PIM1 P11309 1/20 0.41
▸ CDK2 P24941 3/20 0.41
▸ PLK4 O00444 2/20 0.41
▸ DAPK3 O43293 2/20 0.41
▸ DYRK3 O43781 2/20 0.41
▸ ROCK2 O75116 2/20 0.41
▸ CDK1 P06493 2/20 0.41
▸ MARK3 P27448 2/20 0.41
▸ TYK2 P29597 2/20 0.41
▸ CLK2 P49760 2/20 0.41
▸ JAK3 P52333 2/20 0.41
▸ CDK5 Q00535 2/20 0.41
▸ PRKCD Q05655 2/20 0.41
▸ ROCK1 Q13464 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240716 0.91 JAK2 (0.54) JAK2PDPK1MKNK1MKNK2LRRK2
SCHEMBL31240674 0.89 JAK2 (0.48) JAK2PDPK1MKNK2LRRK2MAP4K4
SCHEMBL31240447 0.89 JAK2 (0.48) JAK2PDPK1MKNK2LRRK2MAP4K4
SCHEMBL31240368 0.89 JAK2 (0.48) JAK2PDPK1MKNK2LRRK2MAP4K4
SCHEMBL31240513 0.87 PIM1 (0.50) JAK2MKNK1MKNK2LRRK2PIM1
SCHEMBL31240275 0.86 LRRK2 (0.47) JAK2MKNK1MKNK2LRRK2MAP4K4
SCHEMBL31240440 0.86 JAK2 (0.45) JAK2PDPK1MKNK2LRRK2MAP4K4
SCHEMBL31240422 0.85 JAK2 (0.49) JAK2MKNK2MAP4K4CDK2PLK4
SCHEMBL31240512 0.84 JAK2 (0.52) JAK2PDPK1MKNK2LRRK2MAP4K4
SCHEMBL31240555 0.83 JAK2 (0.55) JAK2PDPK1MKNK2LRRK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback